Nur-Sultan, Kazakhstan

Alexandr V Shustov

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandr V Shustov. Retrieved from https://idiyas.com/inventor/alexandr-v-shustov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexandr V Shustov: Innovator in Flavivirus Research

Introduction

Alexandr V Shustov is a notable inventor based in Astana, Kazakhstan. He has made significant contributions to the field of virology, particularly in the development of a two-component genome flavivirus. His innovative approach has the potential to advance both scientific understanding and practical applications in immunology.

Latest Patents

Shustov holds a patent for a two-component genome flavivirus and its uses. The invention discloses a method for propagating this virus, which is designed to be replication-deficient and incapable of causing disease. However, it can induce an immune response, making it a valuable tool for research and potential therapeutic applications. The design allows for the industrial-level propagation of these flaviviruses, which could lead to advancements in vaccine development.

Career Highlights

Shustov is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His work has garnered attention for its innovative approach to virology and its implications for public health.

Collaborations

Shustov collaborates with Ilya V Frolov, a fellow researcher in the field. Their partnership enhances the scope and impact of their research endeavors.

Conclusion

Alexandr V Shustov's contributions to flavivirus research exemplify the intersection of innovation and practical application in science. His work not only advances our understanding of viral mechanisms but also holds promise for future medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…